Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2010
04/08/2010WO2008100424A3 Animals and cells with genomic target sites for transposase-mediated transgenesis
04/08/2010US20100088786 Leaf-specific chlorophyll a/b binding protein gene promoter from oil palm
04/08/2010US20100088782 Seed enhancement by combinations of pyruvate kinases
04/08/2010US20100088780 Convenient Method for Inhibition of Gene Expression Using RSIS
04/08/2010US20100088779 Loblolly pine tree named '01PM0212'
04/08/2010US20100088778 Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
04/08/2010US20100088775 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same
04/08/2010US20100088774 Characterization of granulocytic ehrlichia and methods of use
04/08/2010US20100087624 Methods for making recombinant proteins using apoptosis inhibitors
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087514 Method and means for treatment of osteoarthritis
04/08/2010US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts
04/08/2010US20100087508 Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
04/08/2010US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
04/08/2010US20100087474 Materials and methods for enhanced degradation of mutant proteins associated with human disease
04/08/2010US20100087464 Protein kinase inhibitors and methods for using thereof
04/08/2010US20100087415 Inhibitors of store operated calcium release
04/08/2010US20100087376 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
04/08/2010US20100087353 Novel Variant EGIII-Like Cellulase Compositions
04/08/2010US20100087336 Functional nucleic acids and methods
04/08/2010US20100087005 Auxiliary reagent for gene transfer
04/08/2010US20100087004 Peptide-presenting surfaces for long-term culture of pluripotent cells
04/08/2010US20100087003 Device and method for the mechanical decollation of cells from a cell composite
04/08/2010US20100087002 Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment
04/08/2010US20100087001 Anti-angiogenic cellular agent for cancer therapy
04/08/2010US20100087000 Hepatic progenitor cell and method of isolating same
04/08/2010US20100086999 Differentiation of primate pluripotent cells to hepatocyte-lineage cells
04/08/2010US20100086998 Enriched Central Nervous System Stem Cell and Progenitor Cell Populations, and Methods For Identifying, Isolating and Enriching For Such Populations
04/08/2010US20100086997 TrkB Agonists for Treating Autoimmune Disorders
04/08/2010US20100086996 Genetically modified human natural killer cell lines
04/08/2010US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
04/08/2010US20100086984 Optoinjection methods
04/08/2010US20100086969 Antibodies That Bind to EphA2 and Methods of Use Thereof
04/08/2010US20100086967 Cell growth
04/08/2010US20100086943 Method for the detection of post-translational modifications
04/08/2010US20100086942 Compounds
04/08/2010US20100086936 Hepatocyte precursor cell lines
04/08/2010US20100086917 Isolated polynucleotides, nucleic acid constructs, methods and kits for localization of rna and/or polypeptides within living cells
04/08/2010US20100086911 Preventive/therapeutic agent for cancer
04/08/2010US20100086610 Vault and vault-like carrier molecules
04/08/2010US20100086560 Chemokines as adjuvants of immune response
04/08/2010US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant
04/08/2010US20100086555 Neutralizing anti-influenza a virus antibodies and uses thereof
04/08/2010US20100086551 Antibody and uses thereof
04/08/2010US20100086545 Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
04/08/2010US20100086542 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists
04/08/2010US20100086538 Antibody Molecules Which Bind to Human IL-17
04/08/2010US20100086537 Polynucleotides and polypeptide sequences involved in cancer
04/08/2010US20100086533 Laglidadg homing endonuclease variants having novel substrate specificity and use thereof
04/08/2010US20100086526 Nucleic acid constructs and methods for specific silencing of h19
04/08/2010US20100086525 Compositions and Methods for Altering Pancreas or Liver Function
04/08/2010US20100086522 Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses
04/08/2010US20100086516 Cytokine receptor chain
04/08/2010US20100086487 Papio cynocephalus Toll-Like Receptor 3
04/08/2010US20100086486 Genetically modified human natural killer cell lines
04/08/2010DE202009017108U1 Monoklonaler Antikörper gegen Microcephalin (MCPH1) Monoclonal antibodies against Microcephalin (MCPH1)
04/08/2010DE102008049136A1 Neue Regulatoren des angeborenen Immunsystems New regulators of the innate immune system
04/08/2010CA2739473A1 New hcv entry factor, occludin
04/08/2010CA2738762A1 A lolium multiflorum line inducing genome loss
04/08/2010CA2738571A1 Production of products of pharmaceutical interest in plant cell cultures
04/08/2010CA2738496A1 Compositions for proliferation of cells and related methods
04/07/2010EP2172560A2 stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
04/07/2010EP2172557A1 Filamentous fungal mutants with improved homologous recombination efficiency
04/07/2010EP2172555A1 Phosphatase stress-related protein and methods of use in plants
04/07/2010EP2172552A2 Recombinant nucleic acids comprising regions of AD6
04/07/2010EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
04/07/2010EP2172548A1 Phosphatidate phosphatase homolog and use of the same
04/07/2010EP2172547A1 Method for expression of specific gene
04/07/2010EP2172543A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
04/07/2010EP2172542A1 Method for constructing mass of myocardial cells and use of the myocardial cell mass
04/07/2010EP2172541A1 Method for production of hepatic-lobule-like cell mass from adipose-tissue-derived cell
04/07/2010EP2172540A1 Flow cytometer having cell-fractionation function and method of fractionating living cells
04/07/2010EP2172486A2 Monoclonal antibody against a prion protein and its use for the detection of prions
04/07/2010EP2172478A2 Activity-dependent neurotrophic factor III (ADNF III)
04/07/2010EP2172476A2 Compositions and methods for WT1 specific immunotherapy
04/07/2010EP2172231A1 Tissue engineering tendon and construction methods in vitro thereof
04/07/2010EP2172227A1 Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
04/07/2010EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof
04/07/2010EP2172101A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same
04/07/2010EP2171069A1 Delivery of nucleic acids into genomes of human stem cells using in vitro assembled mu transposition complexes
04/07/2010EP2171060A2 Superagonistic anti-cd28 antibody
04/07/2010EP2171052A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression
04/07/2010EP2171045A2 Multipotent/pluripotent cells and methods
04/07/2010EP2171044A1 Th-17 cells
04/07/2010EP2171043A1 Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
04/07/2010EP2171042A2 T cell immunomodulation by placenta cell preparations
04/07/2010EP2171040A1 Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
04/07/2010EP2170953A1 Monoclonal anti beta amyloid antibody
04/07/2010EP2170357A1 Delivery of micro-and nanoparticles with blood platelets
04/07/2010EP2170035A1 Modification of plant flavonoid metabolism
04/07/2010EP1907536B1 Cell line for producing coronaviruses
04/07/2010EP1639003B1 Use of cardiotrophin to modulate stem cell proliferation
04/07/2010EP1461431B1 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
04/07/2010EP1450827B1 Use of two-constituent compositions for the in situ production of cell transplants that comprise fibroblasts and keratinocytes
04/07/2010EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
04/07/2010EP1255824B1 Transgenic mice for the study of neurodegenerative syndromes
04/07/2010EP1240331B1 Chlamydia antigens and corresponding dna fragments and uses thereof
04/07/2010EP1196549B1 Controlled electroporation
04/07/2010EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
04/07/2010CN1829667B Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems
1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 1827